PRODUCT LITERATURE

Multisystem hemodynamic effects of terlipressin in cirrhosis

---

Introduction: Hepatorenal syndrome (HRS-AKI) is a serious complication of advanced liver disease. Pharmacologic options are limited in effectiveness, therefore liver transplantation is the definitive therapy. Early investigation into terlipressin as a first-line therapy for HRS-AKI has been promising but expected hemodynamic changes across organ systems in patients with cirrhosis have not been thoroughly examined.

---

Availability

Detail Information

Series Title

-

Call Number

-

Publisher

: .,

Collation

-

Language

English

ISBN/ISSN

-

Classification

NONE

Content Type

LITERATURE

Media Type

-

Carrier Type

-

Edition

-

Subject(s)

Terlipin
Cirrhosis

Specific Detail Info

-

Statement of Responsibility

J Crit Care 87 (2025) 155038

Other version/related

File Attachment

Comments

---

You must be logged in to post a comment